top of page
D3_immuno_TUJ1_PAX6_DAPI_double_blue recolored_edited.jpg

Why invest in DanubeNeuro?

"An investment in knowledge pays the best interest"

-Benjamin Franklin

The longevity and neurodegeneration industry generated $25.1 billion in 2020 and is expected to reach $44.2 billion by 2030, witnessing a CAGR of 6.1% from 2021 to 2030

We keep up to date with emerging trends and rigorously evaluate the developmental state of academic fields to ensure investment in disruptive technologies and assets with high potential returns

Our cross-functional team of experienced entrepreneurs, business developers, and researchers evaluates each academic project for scientific rigor and quality, development feasibility, and commercialization potential to de-risk your investment

Our established network of investors shares our vision for improving the healthspan of the aged population and those suffering from neurodegenerative diseases

Breakthrough projects are managed by experienced professionals

bottom of page